We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
Bacchetta, M.D. and Richter, G. (1996). “Response to ‘Germ-Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum NuclearTransplantation’ by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman (CQ Vol. 4, No 3).”Cambridge Quarterly of Healthcare Ethics5:450–57.Google Scholar
Boone, C.K. (1988). “Bad Axioms in Genetic Engineering.”Hastings Center Report18(4):9–13.Google Scholar
California Statutes1997, ch. 688 (S.B.1344), sec. 5.Google Scholar
Cohen, J., Scott, R., Schimmel, T., Levron, J., and Willadsen, S. (1997). “Birth of Infant after Transfer of Anucleate Donor Oocyte Cytoplasm into Recipient Eggs.”Lancet350:186–87 (July 19).CrossRefGoogle Scholar
Fletcher, J.C. (1985). “Ethical Issues In and Beyond Prospective Clinical Trials of Human Gene Therapy.”Journal of Medicine and Philosophy19:293–309.Google Scholar
Kolata, G. (1997). “Scientists Face New Ethical Quandaries in Baby-Making.”New York Times(August 19).Google Scholar
Rubenstein, D.S., Thomasma, D.C., Schon, E.A., and Zinaman, M.J. (1995). “Germ-Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation.”Cambridge Quarterly of Healthcare Ethics4:316–39.Google Scholar
Zhang, J., Grifo, J., Blaszczk, A., Meng, L., Adler, A., Chin, A., Krey, L., NYU Medical Center Program for IVF, New York, NY, and Oregon Regional Primate Research Center, Beaverton, OR. (1997). “In Vitro Maturation (IVM) of Human Preovulatory Oocytes Reconstructed by Germinal Vesicle (GV) Transfer.”Paper presented at the 53rd Annual Meeting of the American Society for Reproductive Medicine, Cincinnati (Program Supplement).Google Scholar